Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
1.815
-0.085 (-4.47%)
At close: Feb 21, 2025, 4:00 PM
1.820
+0.005 (0.30%)
After-hours: Feb 21, 2025, 5:53 PM EST
Ironwood Pharmaceuticals Employees
Ironwood Pharmaceuticals had 267 employees as of December 31, 2023. The number of employees increased by 48 or 21.92% compared to the previous year.
Employees
267
Change (1Y)
48
Growth (1Y)
21.92%
Revenue / Employee
$1,417,296
Profits / Employee
-$9,225
Market Cap
290.45M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
IRWD News
- 2 days ago - Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call - Business Wire
- 24 days ago - Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future - Business Wire
- 5 weeks ago - Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications - CNBC
- 3 months ago - Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference - Business Wire
- 3 months ago - Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference - Business Wire
- 3 months ago - Ironwood Pharmaceuticals, Inc. (IRWD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Ironwood Pharmaceuticals Reports Third Quarter 2024 Results - Business Wire
- 4 months ago - Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024 - Business Wire